Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 9/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.63 |
| ▸ | APP | P05067 | 6/20 | 0.63 |
| ▸ | SNCA | P37840 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | GMNN | O75496 | 1/20 | 0.63 |
| ▸ | MTOR | P42345 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29609334 | 1.00 | MIF (0.70) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL34474369 | 0.95 | MIF (0.65) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL25850280 | 0.87 | MIF (0.59) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL22625286 | 0.84 | LCK (0.66) | MAPTALDH1A1APPMEN1KMT2A | |
| SCHEMBL136295 | 0.83 | MAPT (0.59) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL2716738 | 0.82 | LCK (0.51) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL19136641 | 0.82 | MIF (0.54) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL31022832 | 0.82 | MAPT (0.57) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL19136640 | 0.82 | MIF (0.54) | MIFMAPTALDH1A1APPSNCA | |
| SCHEMBL10134134 | 0.81 | KMT2A (0.53) | MIFMAPTALDH1A1APPSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0319296-A2 | Photopolymerisable composition | Horsell Plc (GB) | 1989-06-07 | — | — | EP | claimed |
| EP-4208551-A1 | RNA-APTAMER-SENSORS | SenseUp GmbH (DE) | 2023-07-12 | — | — | EP | disclosed |
| WO-2020223439-A1 | AURONES AND METHODS OF USING AURONES TO TREAT TUBERCULOSIS | Middle Tennessee State University (US) | 2020-11-05 | — | — | WO | disclosed |
| US-20110190492-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TOHOKU UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110190492-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TOHOKU UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| US-7910579-B2 | Benzoxazole derivatives | TOHOKU UNIVERSITY (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7910579-B2 | Benzoxazole derivatives | TOHOKU UNIVERSITY (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7910579-B2 | Benzoxazole derivatives | TOHOKU UNIVERSITY (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | TOHOKU UNIVERSITY (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | TOHOKU UNIVERSITY (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | TOHOKU UNIVERSITY (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2103611-A1 | BENZOXAZOLE DERIVATIVES | Tohoku University (JP) | 2009-09-23 | — | — | EP | disclosed |
| US-20090185975-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TOHOKU UNIVERSITY (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090185975-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TOHOKU UNIVERSITY (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090185975-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TOHOKU UNIVERSITY (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1967517-A1 | PROBE FOR DIAGNOSIS OF CONFORMATIONAL DISEASE | TOHOKU UNIVERSITY (JP) | 2008-09-10 | — | — | EP | disclosed |
| EP-0319296-A2 | Photopolymerisable composition | Horsell Plc (GB) | 1989-06-07 | — | — | EP | disclosed |
| US-3973959-A | Electrophotographic recording material and process for its manufacture | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090185975-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TARDBP, LMNA, PMP22 | MIF 3831/4885MAPT 213/4885ALDH1A1 2945/4885 |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | CBX7, KIT, BMX | MIF 4389/4885MAPT 1385/4885ALDH1A1 1195/4885 |
| US-20110190492-A1 | DIAGNOSTIC PROBE FOR CONFORMATION DISEASE | TARDBP, LMNA, PMP22 | MIF 3831/4885MAPT 213/4885ALDH1A1 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.